Continuous‐Time Markov Population PK/PD Modeling of Longitudinal EASI Categorical Score in Atopic Dermatitis Treated With Rocatinlimab, an Anti‐OX40 Monoclonal Antibody

Documenti analoghi

• Population PK – PD Modeling of Danicopan Add‐On Therapy in Participants With Paroxysmal Nocturnal Hemoglobinuria Treated With Ravulizumab or Eculizumab
  di: Jun Chen, et al.
  Pubblicazione: (2026)
• QPRapp: A Web‐Based Platform for PK/PD Simulations and Early Feasibility Analysis
  di: Saroj Dhakal, et al.
  Pubblicazione: (2025)
• Evaluation of the PK / PD Changes on MASLD ‐Related Population—An Example From Simultaneous Acetaminophen Parent‐Metabolite PBPK / PD Modeling
  di: Shanshan Zhao, et al.
  Pubblicazione: (2025)
• The Regularized Horseshoe for Covariate Selection Improves Convenience and Predictive Performance in Population PK / PD Models
  di: Arya Pourzanjani, et al.
  Pubblicazione: (2026)
• A Mechanism‐Based Multi‐Level Population PK/PD Model for Potassium‐Competitive Acid Blockers
  di: Woojin Jung, et al.
  Pubblicazione: (2026)